Press Releases

NASDAQ | TSX: ACBCuraleaf's hostile and opportunistic bid significantly undervalues Aurora, and aims to capture Aurora's assets at a discountAurora is debt free and holds $149 million in cash1, Curaleaf carries over $1 billion in debt2, Aurora shareholders' own cash should not be used to help fix Curaleaf's balance sheetThe hostile bid exposes Aurora shareholders to significant risks not fairly disclosed and could meaningfully weaken shareholder rightsAurora's transformation into a global, high-margin medical cannabis leader is delivering results, and the Board believes significant value creation lies aheadAurora Files Directors' Circular Unanimously Recommending Shareholders REJECT Curaleaf

-- Significant New Program Positioned to Become One of Lifecore’s Largest Contracts -- -- Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Drug Product -- -- Program Expected to Contribute to 2028 Commercial Revenues -- CHASKA, Minn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced it has signed a new agreement to transfer a commercially marketed product to the company’s pipeline. Under the terms of the agreement, Lifecore will perform technical transfer services to support commercial producti

~ Company also announces the submission of a Marketing Authorisation Application for ifezuntirgene inilparvovec in the U.K. ~ ~ Both submissions are supported by the three-year data analysis from the Phase I/II study, in which ifezuntirgene inilparvovec demonstrated a slowing of disease progression ~ LEXINGTON, Mass. and AMSTERDAM, Sept. 02, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the submission of a Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for the accelerated approval of ifezuntirgene inilparvovec

Q2 Total Revenue of $213.7 million, up 1% year-over-year Q2 Subscription Revenue of $194.8 million, up 3% year-over-year Q2 net cash provided by operating activities of $18.2 million, and free cash flow of $13.1 million RPO of $1.03 billion, up 11%, and cRPO up 3% year-over-year Sprinklr (NYSE:CXM), the unified customer experience management (Unified-CXM) platform for modern enterprises, today reported financial results for its second fiscal quarter ended July 31, 2026. "We delivered solid second quarter results and continued to strengthen the fundamentals of the business," said Rory Read, President and CEO of Sprinklr. Read continued, "We believe that the pace of our AI inno

- New release delivers improved performance and area efficiency, scales beyond 250K LUTs, and adds enhanced DSP and optional configuration bit health monitoringSAN JOSE, Calif., Sept. 2, 2026 /PRNewswire/ -- The enhanced eFPGA Hard IP builds on QuickLogic's silicon-proven technology for GF 12LP and expands its capabilities for compute-intensive and high-reliability applications. Key new features include: Enhanced signal processing: A new DSP Multiply-and-Accumulate (MAC) unit, with enhanced preadder, cascade connections, and SIMD functionality, provides greater support for phased array radar, electronic warfare, wireless infras

Teva-discovered TEV ‘408, a novel anti-IL-15 monoclonal antibody, demonstrated statistically significant and clinically meaningful prevention of gluten-induced intestinal damage vs placebo following a single subcutaneous dose.TEV ‘408 was well-tolerated with no safety signals observed to date.Together with the vitiligo program, the celiac disease topline results further support TEV ‘408 as a potential pipeline-in-a-product opportunity in multiple diseases. Teva will hold an investor call and live webcast today,Wednesday, September 2, 2026, at 8:00 a.m. ET to discuss these data. TEL AVIV, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)

New partnership will bring Everspin 256Mb PERSYST MRAM into Teledyne HiRel Semiconductors’ memory solutions for mission-critical systems Everspin Technologies, Inc. (NASDAQ:MRAM), the world’s leading developer and manufacturer of MRAM solutions, and Teledyne HiRel Semiconductors (Teledyne HiRel), a business unit of Teledyne Technologies Incorporated (NYSE:TDY) and a leading supplier of high-reliability semiconductor solutions, today announced a strategic partnership to accelerate adoption of Everspin’s MRAM in aerospace, defense and other demanding systems. This collaboration will begin with the 256Mb PERSYST spin-transfer torque MRAM (STT-MRAM), a non-volatile memory that combines RAM-li

National survey finds AI readiness gap in schools as IBM launches the IBM K-12 AI leaders fellowship for district leaders to support responsible AI adoptionNEW YORK, Sept. 2, 2026 /PRNewswire/ -- IBM (NYSE:IBM) today announced new U.S. research examining AI readiness in K-12 schools and the launch of the IBM K-12 AI leaders fellowship. As schools begin a new academic year, AI is becoming a routine part of K-12 teaching and learning. Yet the survey*, commissioned by IBM and conducted by Morning Consult, finds that the systems supporting responsible AI use are still catching up, pointing to a gap between how quickly AI is enterin

RALEIGH, N.C., Sept. 2, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (NASDAQ:CDNL) ("Cardinal" or the "Company"), announced today that A.L. Grading Contractors (ALGC) has been awarded an approximately $40 million contract to deliver full-site civil infrastructure services for the Carnesville, Georgia, Walmart Sorting Facility. The 164-acre project will be self-performed by ALGC and Allied Paving Contractors, Cardinal's previously announced paving company acquisition expected to close in the fourth quarter. The scope of work includes mass grading of 1.8 million cubic yards; 54,000 linear feet of storm, sewer and wate

Secures extensive U.S. market access for global clients through the addition of 43 state Money Transmitter Licences ("MTLs") under the OpenPayd umbrella through integration of MSB USA Inc. Follows landmark quarter of growth across clients, payments volumes and revenue Solidifies global client offering ahead of OpenPayd’s planned listing on the Nasdaq OpenPayd, a leading provider of financial infrastructure, has announced a significant expansion of its regulatory footprint into the United States, positioning the company for accelerated growth in the critical North American market. The strategic expansion will see the integration of MSB USA Inc. ("MSB USA"), a U.S.-based, state-li

Nebulized Tyvaso® (treprostinil) Inhalation Solution will be the first and only inhaled anti-fibrotic treatment for idiopathic pulmonary fibrosis (IPF) if approved by the U.S. Food and Drug Administration (FDA) United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the FDA has accepted the supplemental New Drug Application (sNDA) for nebulized Tyvaso® (treprostinil) Inhalation Solution to treat IPF. United Therapeutics anticipates the agency's review to be complete in late April 2027. Nebulized Tyvaso has not been approved by the FDA for IPF and remains investigational for this indication. "Nebulized Tyvaso combines direct lung delivery with m

BOSTON and SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (NASDAQ:RAPP) ("Rapport" or the "Company"), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced that management plans to participate in the following upcoming investor events: Cantor Global Healthcare Conference (New York City) – fireside chat on Wednesday, September 9, 2026, at 1:35-2:05 pm ET. TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit (virtual) – fireside chat on Wednesday, September 23, 2026, at 1:30-1:55 pm ET. Interested parties may access

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, in partnership with The Magnum Ice Cream Company, today announced that Popsicle Hard Firecracker will transition to a permanent, year-round flavor in the Popsicle Hard portfolio, following an overwhelmingly positive response from consumers. Originally introduced as a limited-edition seasonal flavor, Firecracker quickly became a fan favorite. Inspired by one of Popsicle’s most recognizable frozen treats, the flavor captures the classic red, white and blue combination of cherry, lemon-lime and blue raspberry notes. Following i

Expanded offerings enable channel partners to deliver end-to-end networking, hybrid cloud, AI, and infrastructure solutions with greater simplicity and scale. Arrow Electronics, Inc. (NYSE:ARW) today announced it has been awarded distribution rights for the HPE Networking product portfolio across North America and select EMEA countries1. The addition expands Arrow's ability to provide channel partners with the complete HPE portfolio, including HPE Aruba Networking and HPE Juniper Networking solutions. The expansion gives channel partners access to a comprehensive set of solutions spanning campus, data center, cloud-managed networking, and AI-native infrastructure. It also strengthens Ar

Solaris Energy Infrastructure, Inc. (NYSE:SEI) ("Solaris" or the "Company"), today announced the acquisition of Omega Foundation Services ("Omega"), a leader in the specialized engineering, procurement and construction ("EPC") industry with significant expertise in heavy civil construction across multiple end markets, including large-scale data centers. Transaction Strategy and Highlights Expands Turnkey Execution Capabilities. Adds to the Company’s full-cycle power solutions, which now include early-stage site services, front-end plant installation & commissioning services and electrical substation development. Addresses Key Industry Bottleneck. Brings in-house a large team of skil

Pairing survey-grade precision with Ouster’s 256-channel Rev8 OS1 Max lidar, GeoCue’s latest TrueView lineup sets a new benchmark for U.S. drone surveying Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, announced a strategic partnership with GeoCue, a premier provider of drone mapping payloads and software, to integrate Ouster’s native color Rev8 OS1 Max digital lidar into GeoCue’s TrueView product line. The collaboration pairs GeoCue's TrueView 1 payloads and LP360 software with Ouster's digital lidar to deliver survey-grade data to the utility and infrastructure industries. This press release features multimedia. View the full

GREENWICH, Conn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE:GXO), the world’s largest pure-play contract logistics provider, today announced that company leaders will present at the following investor conferences: Jefferies Global Industrials ConferencePresenters: Chief Executive Officer Patrick Kelleher and Chief Strategy Officer Kristine KubackiDetails: Wednesday, September 9, 2026, at 8:50AM ET in New York CityWebcast information will be posted to the Company’s Investor Relations website. Morgan Stanley 14th Annual Laguna ConferencePresenters: Chief Financial Officer Mark Suchinski and Chief Strategy Officer Kristine KubackiDetails: Wednesday, September 16, 2026, at

FOSTER CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences. Cantor 2026 Global Healthcare Conference in New York, NY on Wednesday, September 9, 2026, with a fireside chat at 1.35pm ET (link here).H.C. Wainwright 28th Annual Global Investment Conference in New York, NY on Monday, September 14, 2026. The fireside chat will be available in the Investors & Media section of Sagimet’s website at www.sagimet.com, with an archived replay available

Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS), the AI cloud company, today announced that members of its management team will take part in the following investor conferences: Goldman Sachs Communacopia + Technology Conference on September 8, 2026 at 3:45 PM (PT). Citi’s 2026 Global TMT Conference on September 9, 2026 at 7:50 AM (PT). The registration link to the live webcast and a replay of each event will be available on the company’s investor relations website at https://nebius.com/investor-hub. About Nebius Nebius, the AI cloud company, is building the full-stack platform for developers and companies to take charge of their AI future — from data and model

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (NASDAQ:LXEO) a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that members of management will participate in the following investor conferences in September: Cantor Global Healthcare Conference 2026. Fireside chat on Wednesday, September 9, 2026 at 2:10 p.m. ET in New York, NY. Baird 2026 Global Healthcare Conference. Fireside chat on Tuesday, September 15, 2026 at 11:25 a.m. ET in New York, NY. The events will be webcast live under the Events & Presentations tab in the Investors section of the Company’s website. A replay of the webcasts w